NO954390D0 - Method of combating acyclovir-resistant Herpes simplex virus infections - Google Patents

Method of combating acyclovir-resistant Herpes simplex virus infections

Info

Publication number
NO954390D0
NO954390D0 NO954390A NO954390A NO954390D0 NO 954390 D0 NO954390 D0 NO 954390D0 NO 954390 A NO954390 A NO 954390A NO 954390 A NO954390 A NO 954390A NO 954390 D0 NO954390 D0 NO 954390D0
Authority
NO
Norway
Prior art keywords
acyclovir
combating
herpes simplex
simplex virus
virus infections
Prior art date
Application number
NO954390A
Other languages
Norwegian (no)
Other versions
NO954390L (en
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of NO954390D0 publication Critical patent/NO954390D0/en
Publication of NO954390L publication Critical patent/NO954390L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO954390A 1993-05-03 1995-11-02 Method of combating acyclovir-resistant Herpes simplex virus infections NO954390L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections
PCT/CA1994/000242 WO1994025046A1 (en) 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (2)

Publication Number Publication Date
NO954390D0 true NO954390D0 (en) 1995-11-02
NO954390L NO954390L (en) 1996-01-02

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954390A NO954390L (en) 1993-05-03 1995-11-02 Method of combating acyclovir-resistant Herpes simplex virus infections

Country Status (13)

Country Link
EP (1) EP0767671A1 (en)
JP (1) JPH08509476A (en)
KR (1) KR960701651A (en)
CN (1) CN1126438A (en)
AU (1) AU683465B2 (en)
BR (1) BR9406575A (en)
CA (1) CA2095408A1 (en)
CZ (1) CZ287795A3 (en)
HU (1) HUT73779A (en)
NO (1) NO954390L (en)
SG (1) SG48806A1 (en)
SK (1) SK132695A3 (en)
WO (1) WO1994025046A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (en) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 Penciclovir-copper complex, synthetic method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
SG42995A1 (en) * 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
AU683465B2 (en) 1997-11-13
AU6642394A (en) 1994-11-21
HUT73779A (en) 1996-09-30
CZ287795A3 (en) 1996-06-12
EP0767671A1 (en) 1997-04-16
JPH08509476A (en) 1996-10-08
NO954390L (en) 1996-01-02
WO1994025046A1 (en) 1994-11-10
BR9406575A (en) 1996-03-19
SG48806A1 (en) 1998-05-18
HU9503135D0 (en) 1996-01-29
CA2095408A1 (en) 1994-11-04
CN1126438A (en) 1996-07-10
SK132695A3 (en) 1996-10-02
KR960701651A (en) 1996-03-28

Similar Documents

Publication Publication Date Title
DK42093D0 (en) METHOD OF ADMINISTRATION
FI930657A (en) PROCEDURE FOR FRAMING PROCESSING WITH DOSAGE PROCEDURES
FI951986A (en) Wavelength-specific photosensitive porphacyanin and expanded porphyrin-like compounds and their preparation methods and use
FI940167A0 (en) purine derivatives
FI955458A0 (en) Protection that prevents rewetting of rollers
AU3717693A (en) Method of treating and preventing viral infections using HBNF and MK protein
NO940810D0 (en) Treatment of viral infections
NO954390D0 (en) Method of combating acyclovir-resistant Herpes simplex virus infections
AU4688696A (en) Drugs to prevent recurrent herpes virus infections
LV10191A (en) Pharmaceuticals for the treatment of infections and diseases caused by hepatitis B virus
AU2591692A (en) Method of treating latent herpes viral infections
AU9079491A (en) Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
NO983402L (en) Nukeoside analogues in combination therapy of herpes simplex infections
IL110511A0 (en) Topical pharmaceutical formulation for treating viral infections
NO972688D0 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpes virus infections
BR9307043A (en) Process for preparation of dinitro-toluene
AU2414992A (en) Method of combatting hiv infections
FI930237A (en) FRAMING PROCESSING OF 4,6-DIALKOXIPYRIMIDINER
AU5960794A (en) Compositions effective against acyclovir-resistant strains of herpes viruses
MX9201540A (en) DERIVATIVES OF AMIDINE AND PROCESS FOR ITS PREPARATION.
AU4611093A (en) Method of treating viral infections
ES1020264Y (en) SET OF PROFILES FOR HOLDING SHEETS.
AU9073691A (en) Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections
NO933907L (en) cyclone System
BR9306699A (en) Derivatives of triazolylethanol